home / stock / alvo / alvo short
Short Information | Alvotech (NASDAQ:ALVO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 328,911 |
Total Actual Volume | 3,117,795 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 16,446 |
Average Short Percentage | 12.62% |
Is there a ALVO Short Squeeze or Breakout about to happen?
See the ALVO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $12.35 | $12.24 | $12.4 | $12.15 | 168,491 | 24,681 | 14.65% |
07-01-2024 | $12.3 | $12.36 | $12.4 | $12.06 | 230,174 | 15,832 | 6.88% |
06-28-2024 | $12 | $12.16 | $12.16 | $11.8 | 167,044 | 8,526 | 5.1% |
06-27-2024 | $11.93 | $12 | $12.1 | $11.81 | 35,378 | 6,793 | 19.2% |
06-26-2024 | $12.3 | $12.02 | $12.3 | $11.96 | 72,703 | 10,161 | 13.98% |
06-25-2024 | $13.3 | $12.77 | $13.3 | $12.685 | 94,194 | 16,397 | 17.41% |
06-24-2024 | $13.5 | $13.32 | $13.5 | $13.1 | 211,663 | 10,473 | 4.95% |
06-21-2024 | $13.79 | $13.48 | $13.79 | $13.31 | 123,714 | 24,992 | 20.2% |
06-20-2024 | $13.5 | $13.51 | $13.65 | $13.27 | 407,158 | 16,611 | 4.08% |
06-18-2024 | $13.8 | $13.64 | $13.81 | $13.4001 | 154,329 | 24,402 | 15.81% |
06-17-2024 | $14.14 | $13.85 | $14.14 | $13.65 | 442,243 | 12,947 | 2.93% |
06-14-2024 | $14.32 | $14.05 | $14.32 | $14.035 | 64,520 | 3,853 | 5.97% |
06-13-2024 | $14.25 | $14.28 | $14.2899 | $14.1 | 84,574 | 6,853 | 8.1% |
06-12-2024 | $14.65 | $14.23 | $14.65 | $14.16 | 173,741 | 3,911 | 2.25% |
06-11-2024 | $14.46 | $14.39 | $14.46 | $14.37 | 86,252 | 15,153 | 17.57% |
06-10-2024 | $13.98 | $14.46 | $14.525 | $13.63 | 218,232 | 39,253 | 17.99% |
06-07-2024 | $14.07 | $14.04 | $14.14 | $13.965 | 144,393 | 29,094 | 20.15% |
06-06-2024 | $13.99 | $13.99 | $14 | $13.9438 | 79,725 | 6,598 | 8.28% |
06-05-2024 | $13.88 | $13.95 | $13.95 | $13.81 | 39,712 | 1,797 | 4.53% |
06-04-2024 | $13.86 | $13.91 | $13.99 | $13.7 | 119,555 | 50,584 | 42.31% |
News, Short Squeeze, Breakout and More Instantly...
Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia ® (denosumab) Two additional studies comparing the pharmacokinetics, safety, and tolerability of AVT03 to Prolia and Xgeva, respectively, have also met their primary endp...
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvote...
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced certain preliminary, unaudited key financial information for the second quarter a...